Cubist Systematic Strategies’s Pacific Biosciences PACB Stock Holding History

Cubist Systematic Strategies’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-247,209	Closed	-$927K	–	3757
2024 Q1	$927K	Buy	247,209 +106,775	+76%	+$625K	0.01%	2235
2023 Q4	$1.38M	Buy	140,434 +77,502	+123%	+$634K	0.01%	1802
2023 Q3	$525K	Buy	+62,932	New	+$719K	﹤0.01%	2291
2023 Q2	–	Sell	-20,751	Closed	-$240K	–	4094
2023 Q1	$240K	Sell	20,751 -4,744	-19%	-$47.2K	﹤0.01%	3130
2022 Q4	$209K	Sell	25,495 -127,845	-83%	-$1.1M	﹤0.01%	3558
2022 Q3	$890K	Sell	153,340 -633,030	-81%	-$3.63M	0.01%	2716
2022 Q2	$3.48M	Buy	786,370 +163,876	+26%	+$996K	0.02%	1325
2022 Q1	$5.67M	Buy	622,494 +577,366	+1,279%	+$6.65M	0.05%	623
2021 Q4	$923K	Buy	+45,128	New	+$1.09M	0.01%	1974
2021 Q1	–	Sell	-57,266	Closed	-$1.49M	–	2941
2020 Q4	$1.49M	Buy	57,266 +56,265	+5,621%	+$956K	0.02%	1133
2020 Q3	$10K	Sell	1,001 -27,895	-97%	-$161K	﹤0.01%	2435
2020 Q2	$100K	Buy	+28,896	New	+$98.4K	﹤0.01%	2192
2019 Q3	–	Sell	-4,600	Closed	-$28K	–	2398
2019 Q2	$28K	Buy	+4,600	New	+$32.3K	﹤0.01%	2369
2018 Q4	–	Sell	-9,409	Closed	-$51K	–	2226
2018 Q3	$51K	Buy	+9,409	New	+$40.4K	﹤0.01%	1704
2017 Q4	–	Sell	-10,476	Closed	-$55K	–	2052
2017 Q3	$55K	Buy	+10,476	New	+$45K	﹤0.01%	1721
2017 Q2	–	Sell	-1,527	Closed	-$8K	–	1826
2017 Q1	$8K	Buy	+1,527	New	+$7.47K	﹤0.01%	1569
2016 Q2	–	Sell	-4,453	Closed	-$38K	–	1833
2016 Q1	$38K	Sell	4,453 -11,371	-72%	-$112K	﹤0.01%	1494
2015 Q4	$208K	Buy	15,824 +13,830	+694%	+$124K	0.01%	1332
2015 Q3	$7K	Buy	1,994 +221	+12%	+$1.08K	﹤0.01%	1814
2015 Q2	$10K	Sell	1,773 -17,227	-91%	-$99.7K	﹤0.01%	1774
2015 Q1	$111K	Sell	19,000 -700	-4%	-$4.83K	0.01%	1649
2014 Q4	$154K	Buy	19,700 +6,400	+48%	+$41K	0.01%	1591
2014 Q3	$65K	Buy	13,300 +2,981	+29%	+$15.6K	﹤0.01%	1608
2014 Q2	$64K	Buy	+10,319	New	+$51.6K	﹤0.01%	1383